Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Cash & Short-Term Investments

$50.83M

Quarterly · Period ending: · USD

LCTX logo

LCTX Cash & Short-Term Investments

Latest reported$50.83M
LCTX Quarterly Cash & Short-Term Investments ($5.10M → $50.83M)
High-resolution chart · PNG

LCTX cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
192,973
321,512
1,318,338
2,020,624
2,426,876
3,687,377
5,292,806
6,600,000
7,200,000
8,600,000
3,300,000
4,100,000
5,100,000
6,300,000
7,400,000
7,800,000
7,300,000
2,400,000
2,000,000
2,400,000
2,900,000
3,400,000
900,000
700,000
200,000
700,000
1,300,000
2,700,000
1,100,000
1,500,000
3,800,000
4,100,000
4,400,000
4,800,000
5,100,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.